Immunohistochemical expression of cyclooxygenase-2 (COX-2) is not associated with tumor grade in feline meningiomas

F. Samarani, Cristian De La Fuente Hernandez, A. Parodi, M. T. Mandara, Marti Pumarola Batlle, Sonia Añor Torres*

*Corresponding author for this work

Research output: Contribution to journalArticleResearch

4 Citations (Scopus)


© 2018 Elsevier Ltd Meningioma is the most common primary brain tumor in cats and occurs less frequently in the spinal cord. This study aimed to investigate cyclooxygenase-2 (COX-2) expression in feline meningiomas, and the possible association between COX-2 immunoreactivity and tumor grade using eight low-grade and seven high-grade meningiomas. All tumors (n = 15/15) were immunoreactive to COX-2. The expression of COX-2 was not significantly correlated with tumor grade (P = 0.22 and 0.34 for staining and intensity, respectively) but was significantly associated with necrosis (P = 0.04 and 0.01 for staining and intensity, respectively). The findings in this study suggest that feline meningiomas express COX-2, but there were no differences in COX-2 immunoreactivity patterns between low- and high-grade meningiomas. However, the association between COX-2 expression and the presence of necrosis indicates a potential area for therapeutic intervention with selective COX-2 inhibitors.
Original languageEnglish
Pages (from-to)20-23
JournalVeterinary Journal
Publication statusPublished - 1 Nov 2018


  • Cats
  • COX-2
  • Immunohistochemistry
  • Meningioma


Dive into the research topics of 'Immunohistochemical expression of cyclooxygenase-2 (COX-2) is not associated with tumor grade in feline meningiomas'. Together they form a unique fingerprint.

Cite this